Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Cash (2020 - 2025)

Historic Change in Cash for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $17.8 million.

  • Cytek Biosciences' Change in Cash rose 21405.7% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.0 million, marking a year-over-year decrease of 510535.44%. This contributed to the annual value of -$68.9 million for FY2024, which is 4776.29% up from last year.
  • Latest data reveals that Cytek Biosciences reported Change in Cash of $17.8 million as of Q3 2025, which was up 21405.7% from -$19.8 million recorded in Q2 2025.
  • Cytek Biosciences' Change in Cash's 5-year high stood at $409.2 million during Q4 2021, with a 5-year trough of -$204.4 million in Q3 2021.
  • Over the past 5 years, Cytek Biosciences' median Change in Cash value was -$3.4 million (recorded in 2025), while the average stood at -$3.8 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 9931310.68% in 2021, then skyrocketed by 113258.82% in 2024.
  • Cytek Biosciences' Change in Cash (Quarter) stood at $409.2 million in 2021, then plummeted by 110.27% to -$42.0 million in 2022, then skyrocketed by 109.52% to $4.0 million in 2023, then crashed by 1688.55% to -$63.6 million in 2024, then soared by 128.02% to $17.8 million in 2025.
  • Its Change in Cash was $17.8 million in Q3 2025, compared to -$19.8 million in Q2 2025 and -$3.4 million in Q1 2025.